文献速递生殖医学

一项双盲随机对照试验:研究用于选择第5天囊胚移植的时差成像算法

A double-blind randomized controlled trial investigating a time-lapse algorithm for selecting Day 5 blastocysts for transfer.
PubMed 文献 · Hum Reprod · 2022-01-01

这项前瞻性多中心随机对照试验纳入776例患者,比较商业时差成像模型与单纯形态学选择第5天囊胚进行新鲜单胚胎移植的效果。时差成像组持续妊娠率为47.4%(175/369),对照组为48.1%(181/376),两组无统计学显著差异,平均差-0.7%(95%CI -8.2, 6.7,P=0.90)。

要点

  • 时差成像选择未提高持续妊娠率:47.4% vs 48.1%,平均差-0.7%(95%CI -8.2, 6.7,P=0.90)。
  • 妊娠率60.2% vs 59.0%,早期妊娠丢失21.2% vs 18.5%,两组均无统计学显著差异。
  • 应用算法后42%(154/369,95%CI 36.9, 47.2)的情况下最佳囊胚选择发生改变。

核心结论

  • 时差成像选择模型选择第5天新鲜单胚胎移植的囊胚,与单纯形态学相比未改善持续妊娠率。

研究设计与样本

  • 前瞻性多中心随机对照试验,2018年至2021年间纳入776例患者,按1:1随机分为对照组(单纯形态学选择,389例)和干预组(商业时差成像模型选择,387例)。
  • 纳入标准为第5天至少有2个优质囊胚,仅进行新鲜周期单胚胎移植;来自10家北欧IVF诊所。
  • 主要结局为两组持续妊娠数;胚胎学家在形态学评分时对分组盲,医生和患者对分组盲直至主要结局知晓。

主要发现

  • 全分析集中,时差成像组持续妊娠率为47.4%(175/369),对照组为48.1%(181/376),平均差-0.7%(95%CI -8.2, 6.7,P=0.90),无统计学显著差异。
  • 妊娠率时差成像组60.2% vs 对照组59.0%,平均差1.1%(95%CI -6.2, 8.4,P=0.81);早期妊娠丢失时差成像组21.2% vs 对照组18.5%,平均差2.7%(95%CI -5.2, 10.6,P=0.55)。
  • 亚组分析显示患者和治疗特征未显著影响商业时差成像模型第5天性能;时差成像组应用算法后42%(154/369,95%CI 36.9, 47.2)的情况下最佳囊胚选择发生改变,大多数治疗诊所该比例相似。

临床怎么用

  • 原文结论指出,与单纯形态学相比,使用商业时差成像模型选择第5天单囊胚移植未增加持续妊娠机会。

局限性

  • 2020年因冠状病毒病-19限制,参与诊所招募速度减慢,目标样本量未达到计划,决定提前终止试验。
  • 研究仅调查第5天囊胚阶段的新鲜IVF移植周期中的胚胎选择。
  • 仅考虑形态学优质囊胚进行移植,限制了两组可供选择的胚胎数量;也可认为这种手动预选囊胚限制了时差成像的理论选择能力,并将结果主要限制在预后良好患者组。
  • 大多数患者的目标是当至少5个合子可用于延长培养时进行囊胚阶段移植。
  • 评估的主要临床结局仅为妊娠至6-8周。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Can use of a commercially available time-lapse algorithm for Day 5 blastocyst selection improve pregnancy rates compared with morphology alone? SUMMARY ANSWER: The use of a time-lapse selection model to choose blastocysts for fresh single embryo transfer on Day 5 did not improve ongoing pregnancy rate compared to morphology alone. WHAT IS KNOWN ALREADY: Evidence from time-lapse monitoring suggests correlations between timing of key developmental events and embryo viability. No good quality evidence exists to support improved pregnancy rates following time-lapse selection. STUDY DESIGN, SIZE, DURATION: A prospective multicenter randomized controlled trial including 776 randomized patients was performed between 2018 and 2021. Patients with at least two good quality blastocysts on Day 5 were allocated by a computer randomization program in a proportion of 1:1 into either the control group, whereby single blastocysts were selected for transfer by morphology alone, or the intervention group whereby final selection was decided by a commercially available time-lapse model. The embryologists at the time of blastocyst morphological scoring were blinded to which study group the patients would be randomized, and the physician and patients were blind to which group they were allocated until after the primary outcome was known. The primary outcome was number of ongoing pregnancies in the two groups. PARTICIPANTS/MATERIALS, SETTING, METHODS: From 10 Nordic IVF clinics, 776 patients with a minimum of two good quality blastocysts on Day 5 (D5) were randomized into one of the two study groups. A commercial time-lapse model decided the final selection of blastocysts for 387 patients in the intervention (time-lapse) group, and blastocysts with the highest morphological score were transferred for 389 patients in the control group. Only single embryo transfers in fresh cycles were performed. MAIN RESULTS AND THE ROLE OF CHANCE: In the full analysis set, the ongoing pregnancy rate for the time-lapse group was 47.4% (175/369) and 48.1% (181/376) in the control group. No statistically significant difference was found between the two groups: mean difference -0.7% (95% CI -8.2, 6.7, P = 0.90). Pregnancy rate (60.2% versus 59.0%, mean difference 1.1%, 95% CI -6.2, 8.4, P = 0.81) and early pregnancy loss (21.2% versus 18.5%, mean difference 2.7%, 95% CI -5.2, 10.6, P = 0.55) were the same for the time-lapse and the control group. Subgroup analyses showed that patient and treatment characteristics did not significantly affect the commercial time-lapse model D5 performance. In the time-lapse group, the choice of best blastocyst changed on 42% of occasions (154/369, 95% CI 36.9, 47.2) after the algorithm was applied, and this rate was similar for most treatment clinics. LIMITATIONS, REASONS FOR CAUTION: During 2020, the patient recruitment rate slowed down at participating clinics owing to coronavirus disease-19 restrictions, so the target sample size was not achieved as planned and it was decided to stop the trial prematurely. The study only investigated embryo selection at the blastocyst stage on D5 in fresh IVF transfer cycles. In addition, only blastocysts of good morphological quality were considered for transfer, limiting the number of embryos for selection in both groups: also, it could be argued that this manual preselection of blastocysts limits the theoretical selection power of time-lapse, as well as restricting the results mainly to a good prognosis patient group. Most patients were aimed for blastocyst stage transfer when a minimum of five zygotes were available for extended culture. Finally, the primary clinical outcome evaluated was pregnancy to only 6-8 weeks. WIDER IMPLICATIONS OF THE FINDINGS: The study suggests that time-lapse selection with a commercially available time-lapse model does not increase chance of ongoing pregnancy after single blastocyst transfer on Day 5 compared to morphology alone. STUDY FUNDING/COMPETING INTEREST(S): The study was financed by a grant from the Swedish state under the ALF-agreement between the Swedish government and the county councils (ALFGBG-723141). Vitrolife supported the study with embryo culture dishes and culture media. During the study period, T.H. changed his employment from Livio AB to Vitrolife AB. All other authors have no conflicts of interests to disclose. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov registration number NCT03445923. TRIAL REGISTRATION DATE: 26 February 2018. DATE OF FIRST PATIENT’S ENROLMENT: 11 June 2018.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ahlström A, Lundin K, Lind AK, et al. A double-blind randomized controlled trial investigating a time-lapse algorithm for selecting Day 5 blastocysts for transfer. Hum Reprod. 2022. PMID: 35143661. doi:10.1093/humrep/deac020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。